UCB's Global Corporate Website

This section is intended for media and financial analysts

Search Press releases

4 Oct 2013

UCB announces scientific presentations on romosozumab at the annual meeting of the American Society for Bone and Mineral Research 2013

Read More
30 Sep 2013

Cimzia® (certolizumab pegol) approved by the U.S. FDA for treatment of adult patients with active psoriatic arthritis

Read More
30 Sep 2013

Vectura and UCB to collaborate and share expertise in severe inflammatory disease

Read More
27 Sep 2013

UCB completes institutional Eurobond offering

Read More
27 Sep 2013

UCB launches institutional Eurobond offering

Read More
20 Sep 2013

Results of the public exchange offer on the bonds maturing in November 2014

Read More

Stay up-to-date on the latest news and information from UCB